Last Updated: Sep 29, 2016
- A comprehensive meta-analysis of genetic associations between five key SNPs and colorectal cancer risk.
Hong Yi, et al. Oncotarget 2016 9 - Patients with Metastatic Colorectal Cancer and Hyperbilirubinemia Treated with FOLFIRI plus Bevacizumab as First-Line Treatment.
Huang Ching-Wen, et al. Chemotherapy 2016 9 (1) 80-84 - The COMET Open-label Phase II Study of Neoadjuvant FOLFOX or XELOX Treatment Combined with Molecular Targeting Monoclonal Antibodies in Patients with Resectable Liver Metastasis of Colorectal Cancer.
Kataoka Masato, et al. Annals of surgical oncology 2016 9 - Germline miRNA DNA Variants and the Risk of Colorectal Cancer by Subtype.
Lindor Noralane M, et al. Genes, chromosomes & cancer 2016 9 - Pharmacogenetic and ethnicity influence on oxaliplatin therapy for colorectal cancer: a meta-analysis.
Shahnam Adel, et al. Pharmacogenomics 2016 9 - Association of monoallelic MUTYH mutation among Egyptian patients with colorectal cancer.
Elsaid Afaf, et al. Familial cancer 2016 9 - Plasma miR-122 and miR-200 family are prognostic markers in colorectal cancer.
Maierthaler Melanie, et al. International journal of cancer 2016 9 - Study of apoptosis-related interactions in colorectal cancer.
Arora Himanshu, et al. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2016 9 - Association of adiponectin receptor 1 gene - 106 C > T variant with susceptibility to colorectal cancer.
Mahmoudi Touraj, et al. Meta gene 2016 9 210-4 - The somatic POLE P286R mutation defines a unique subclass of colorectal cancer featuring hypermutation, representing a potential genomic biomarker for immunotherapy.
Ahn Sung-Min, et al. Oncotarget 2016 9 - A 19-Gene expression signature as a predictor of survival in colorectal cancer.
Abdul Aziz Nurul Ainin et al. BMC medical genomics 2016 9(1) 58 - A copy number variation in PKD1L2 is associated with colorectal cancer predisposition in Korean population.
Park Changho, et al. International journal of cancer 2016 9 - Connecting cancer biology and clinical outcomes to imaging in KRAS mutant and wild-type colorectal cancer liver tumors following selective internal radiation therapy with yttrium-90.
Magnetta Michael J, et al. Abdominal radiology (New York) 2016 9 - Phenotypic consequences of somatic mutations in the ataxia-telangiectasia mutated gene in non-small cell lung cancer.
Weber Anika Maria, et al. Oncotarget 2016 9 - Murine MTHFD1-synthetase deficiency, a model for the human MTHFD1 R653Q polymorphism, decreases growth of colorectal tumors.
Lévesque Nancy, et al. Molecular carcinogenesis 2016 9
- Human (4069)
- Pathogen (0)
- Human (235)
- Pathogen (0)
- Huamn (83)
- Pathogen (0)
.png)
No hay comentarios:
Publicar un comentario